February 18, 2008 –ProCure Treatment Centers Inc. and the University of Pennsylvania’s Roberts Proton Therapy Center have an agreement to provide advanced training programs and accredit medical professionals in proton therapy, an alternative to conventional radiation therapy that avoids many of the side effects inherent in treatment.

The agreement focuses on expanding research on the technology to be used for the delivery of proton therapy and developing new protocols using protons to treat a wider range of cancer tumors.

Protons are currently used primarily to treat about a dozen diagnoses including base-of-skull tumors, ocular melanoma, sinus tumors, pediatric cancers and prostate cancer. As more centers are developed and the capacity for patients increases, the Roberts Proton Therapy Center and ProCure have agreed to establish new clinical studies to evaluate the use of protons in areas such as proton therapy in combination with chemotherapy and the improved results obtained from increasing the dose delivered to the tumor. ProCure’s network of proton therapy centers will significantly increase the number of patients that can potentially be enrolled in studies, according to the company. The Center will provide oversight, establish data collection procedures, analyze data and work through any necessary regulatory process.

It is anticipated that within the next five years, at least 10 new proton therapy facilities will open in the U.S., including the Roberts Proton Therapy Center and several centers under development by ProCure, resulting in a need for trained staff at all levels. The Center and ProCure intend to collaborate on setting standards for proton therapy education and training, and will offer accreditation in the field. Training programs are slated to be provided at the ProCure Training and Development Center (TDC), a training center dedicated exclusively to proton therapy. The 20,000-square-foot training facility is located in Bloomington, IN. The TDC simulates a working proton therapy center and will provide training for radiation oncologists, medical physicists, dosimetrists, radiation therapists and other staff.

For more information: www.procurenews.com


Related Content

News | Artificial Intelligence

May 14, 2024 — Elekta announced the launch of its latest linear accelerator (linac), Evo*, a CT-Linac with new high ...

Time May 14, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Insurance expansions under the Affordable Care Act (ACA) were linked with an increase in patients ...

Time May 10, 2024
arrow
News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Subscribe Now